课题基金 / 基金详情

项目摘要

项目成果

Dustin J Maly的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 GT-RAS作为分子“开/关”开关发挥作用,存在于GDP结合(无活性)和GTP结合(无活性)中。 绑定表单(活动)。尽管作为一个简单的二进制开关,RAS是能够指导复杂的, 不同的细胞过程,包括增殖、迁移、存活和T细胞发育。最近的工作 表明RAS在不同过程中扮演复杂的、经常相互冲突的角色的能力来自于 细胞环境和/或其信号传导的亚细胞定位的差异。我们已经开发出一种新颖 化学遗传工具-称为RAS的化学诱导激活剂(CIAR)-研究RAS的动力学。 RAS活性介导的信号网络。CIAR允许快速和剂量依赖性激活 RAS信号转导与细胞可渗透的小分子。通过CIAR,我们建议使用有针对性的,定量的 磷酸蛋白质组学和转录组学来研究RAS驱动的信号传导的基本动态行为。 亚细胞定位版本的CIAR也将用于确定局部RAS激活的影响, RAS介导的信号动力学。最后,我们将探讨积极和消极的反馈, RAS驱动的信号通路通过选择性增强或抑制下游信号组分。
英文摘要
Abstract The GTPase RAS functions as a molecular “on/off” switch, existing both in GDP-bound (inactive) and GTP- bound forms (active). Despite functioning as a simple binary switch, RAS is capable of directing complex and diverse cellular processes, including proliferation, migration, survival, and T-cell development. Recent work suggests that the ability of RAS to play complex, often conflicting roles in diverse processes results from differences in cellular context and and/or subcellular localization of its signaling. We have developed a novel chemical genetic tool–called Chemically-Inducible Activator of RAS (CIAR)–to study the dynamics of the signaling networks that are mediated by RAS activity. CIAR allows rapid and dose-dependent activation of RAS signaling with a cell permeable small molecule. With CIAR, we propose to use targeted, quantitative phosphoproteomics and transcriptomics to study the fundamental dynamic behavior of RAS-driven signaling. Subcellularly-localized versions of CIAR will also be used to determine the effects of localized RAS activation on the dynamics of RAS-mediated signaling. Finally, we will explore positive and negative feedback within RAS-driven signaling pathways by selectively enhancing or inhibiting downstream signaling components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Genetic Analysis of RAS Signaling
  • 批准号:
    10589943
  • 项目类别:
  • 资助金额:
    $32.78万
  • 财政年份:
    2022
  • 负责人:
    Dustin J Maly
  • 依托单位:
Chemical Genetic Analysis of RAS Signaling
  • 批准号:
    10642578
  • 项目类别:
  • 资助金额:
    $4.11万
  • 财政年份:
    2022
  • 负责人:
    Dustin J Maly
  • 依托单位:
Partial Antagonists of IRE1 RNaseââPAIRâsâto treat Type 1 Diabetes
Partial Antagonists of IRE1 RNase--'PAIR's--to treat Type 1 Diabetes
海外基金